Mersana Therapeutics, Inc. (MRSN)

NASDAQ: MRSN · Real-Time Price · USD

27.30

-0.21 (-0.76%)

At close: Nov 21, 2025, 4:00 PM EST

27.00

-0.30 (-1.10%)

After-hours: Nov 21, 2025, 7:45 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Antibody-drug Conjugates	40.50M	Log In	Log In	Log In	Log In	Upgrade
Antibody-drug Conjugates Growth	9.88%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	40.50M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	9.88%	Log In	Log In	Log In	Log In	Upgrade